In Reply
- PMID: 32217962
- DOI: 10.1097/AOG.0000000000003813
In Reply
Comment on
-
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.Obstet Gynecol. 2019 Nov;134(5):921-931. doi: 10.1097/AOG.0000000000003503. Obstet Gynecol. 2019. PMID: 31599845 Free PMC article.
-
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.Obstet Gynecol. 2020 Apr;135(4):975. doi: 10.1097/AOG.0000000000003812. Obstet Gynecol. 2020. PMID: 32217961 Free PMC article. No abstract available.
References
-
- Premkumar A, Grobman WA, Terplan M, Miller ES. Methadone, buprenorphine, or detoxification for management of perinatal opioid use disorder: a cost-effectiveness analysis. Obstet Gynecol 2019;134:921–31.
-
- Bell J, Towers CV, Hennessy MD, Heitzman C, Smith B, Chattin K. Detoxification from opiate drugs during pregnancy. Am J Obstet Gynecol 2016;215:374.e1–6.
-
- Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 2000;283:1303–10.
-
- Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol 2018;132:466–74.
-
- Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, et al. Opioid detoxification during pregnancy: a systematic review. Obstet Gynecol 2018;131:803–14.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
